- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: MK-0653, ezetimibe
Total 2127 results
-
Merck Sharp & Dohme LLCCompletedKidney Failure, Chronic | End-Stage Renal Disease (ESRD) | End-Stage Kidney Disease (ESKD)Japan
-
Merck Sharp & Dohme LLCActive, not recruitingPIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)United States, Australia, Brazil, Italy, United Kingdom
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Worldwide Clinical TrialsTerminatedPIK3CA-Related Overgrowth Spectrum (PROS)/Proteus SyndromeUnited States, Australia, Italy, Spain
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCTerminatedType 2 Diabetes
-
Merck Sharp & Dohme LLCCompleted
-
Daewoong Pharmaceutical Co. LTD.Recruiting
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Switzerland, United States
-
Organon and CoCompleted
-
Yonsei UniversityCompletedDyslipidemias | Nonalcoholic Fatty Liver DiseaseKorea, Republic of
-
Mersin UniversityCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCRecruitingPrimary Myelofibrosis | Polycythemia Vera | Thrombocythemia, Essential | Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisAustralia, New Zealand
-
Acceleron Pharma, Inc., a wholly-owned subsidiary...RecruitingPulmonary Arterial Hypertension | PAHUnited States, France, Germany, Spain, Sweden, Argentina, Australia, Austria, Colombia, Croatia, Denmark, Greece, Israel, Italy, Korea, Republic of, Netherlands, New Zealand, Portugal, Serbia, Taiwan, United Kingdom, Brazil, Canada, B... and more
-
Acceleron Pharma, Inc., a wholly-owned subsidiary...Active, not recruitingSystemic Sclerosis With and Without Interstitial Lung DiseaseUnited States, Canada, Italy, Switzerland
-
Merck Sharp & Dohme LLCActive, not recruitingHematological MalignanciesChina
-
Afferent Pharmaceuticals, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruiting
-
Seung-Whan Lee, M.D., Ph.D.Yuhan CorporationRecruitingPre Diabetes | ASCVDKorea, Republic of
-
Organon and CoCompleted
-
Organon and CoCompleted
-
Yonsei UniversityUnknownType 2 Diabetes Mellitus | DyslipidemiasKorea, Republic of
-
Hospital Universitario 12 de OctubreMerck Sharp & Dohme LLCCompletedCardiovascular Diseases
-
Walter Reed Army Medical CenterAbbottTerminatedAtherosclerosisUnited States
-
Organon and CoCompleted
-
NovartisCompletedDyslipidemiaGermany, Switzerland
-
Organon and CoCompletedSpondylarthropathies; Spondylitis, Ankylosing
-
Organon and CoCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedAdvanced/Metastatic Solid TumorsUnited States, Canada
-
Merck Sharp & Dohme LLCTerminated
-
Organon and CoMerck Sharp & Dohme LLCCompletedHypercholesterolemia | Hyperlipidemia
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaChina, India, Thailand
-
Kumamoto UniversityCompletedCoronary Artery Disease | HypercholesterolemiaJapan
-
Merck Sharp & Dohme LLCActive, not recruitingKidney Failure, Chronic | End-Stage Renal Disease | End-Stage Kidney DiseaseUnited States, Argentina, Australia, Brazil, Bulgaria, Canada, Czechia, Germany, Greece, Italy, Portugal, Puerto Rico, Romania, Russian Federation, Sweden
-
Afferent Pharmaceuticals, Inc.CompletedOsteoarthritis of the KneeUnited States
-
University of VirginiaMerck Sharp & Dohme LLC; National Institutes of Health (NIH)WithdrawnChronic Kidney Disease | Kidney DiseaseUnited States
-
Dar Al Shifa HospitalCompletedLasik in Myopia
-
Merck Sharp & Dohme LLCNot yet recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Samsung Medical CenterNot yet recruitingMetabolic Syndrome | Dyslipidemias | Coronary Artery Calcification
-
Organon and CoCompleted
-
Organon and CoMerck Sharp & Dohme LLCCompletedAtherosclerosis | Hypercholesterolemia
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Beijing Anzhen HospitalBeijing Municipal Health CommissionRecruiting
-
National Cancer Institute (NCI)Active, not recruitingStage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Advanced Malignant Solid Neoplasm | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma... and other conditionsUnited States